Denkert, C., Huober, J., Loibl, S., Prinzler, J., Kronenwett, R., Darb-Esfahani, S., . . . Untch, M. (2016). HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).
Chicago-Zitierstil (17. Ausg.)Denkert, Carsten, et al. HER2 and ESR1 MRNA Expression Levels and Response to Neoadjuvant Trastuzumab Plus Chemotherapy in Patients with Primary Breast Cancer. Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016.
MLA-Zitierstil (9. Ausg.)Denkert, Carsten, et al. HER2 and ESR1 MRNA Expression Levels and Response to Neoadjuvant Trastuzumab Plus Chemotherapy in Patients with Primary Breast Cancer. Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016.